Yavuz B, Morgan JL, Herrera C, Harrington K, Perez-Ramirez B, LiWang PJ, Kaplan DL. Sustained Release Silk Fibroin Discs: Antibody and Protein Delivery for HIV Prevention. Controlled Release. 2019;301:1–12.

Yavuz B, Morgan JL, Showalter L, Horng KR, Dandekar S, Herrera C, LiWang P, Kaplan DL. Pharmaceutical Approaches to HIV Treatment and Prevention. Advanced Therapeutics. 2018. doi:10.1002/adtp.201800054

Nguyen AF, Kuo N-W, Showalter L, Ramos R, Dupureur CM, Colvin ME, LiWang PJ. Biophysical and Computational Studies of the vCCI:vMIP-II complex. International Journal of Molecular Sciences. 2017;(18:8). doi:10.3390/ijms18081778

Nguyen AF, Schill MS, Jian M, LiWang PJ. The effect of N-terminal cyclization on the function of the HIV entry inhibitor 5P12-RANTES. International Journal of Molecular Sciences. 2017;(18:7). doi:10.3390/ijms1807157

Zhang L, Herrera C, Coburn J, Olejniczak N, Ziprin P, Kaplan D, LiWang PJ. Sustained release and stability to high temperatures of HIV inhibitors by encapsulation in silk fibroin disks. ACS:Biomaterials. 2017. doi:10.1021/acsbiomaterials.7b00167

Fischer K, Nguyen K, LiWang PJ. Determination of Glycosylation Sites Necessary for Griffithsin Potency Against HIV Infection. AIDS Research and Human Retroviruses. 2016;32:236.

Zhang L, Herrera C, Coburn J, Showalter L, Kaplan D, LiWang PJ. Silk Fibroin provides both temperature stabilization and sustained release of protein HIV inhibitors. AIDS Research and Human Retroviruses. 2016;32:225.

Herrera C, N O, L Z, J C, D K, LiWang PJ. Silk-formulated Antiretrovirals as Candidate Microbicides. AIDS Research and Human Retroviruses. 2016;32:210–210.

Kuo N-W, Gao Y-G, Schill MS, Isern N, Dupurerur CM, LiWang PJ, Chem B. Structural insights into the interaction between a potent anti-inflammatory protein, vCCI and the human CC chemokine, Eotaxin-1. 2014;289:6592–6603.

Zhang L, LiWang PJ. Chemokine-receptor interactions: Solving the puzzle, piece by piece. 2014;22:1550–1552.